CapsoVision, Inc (CV) stock
CVNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30383% above fair value
$6.03−0.24 (-3.83%)
Close on Nov 13, 2026Market cap $301.78MP/E –Yield –
CapsoVision price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
CapsoVision's price to sales ratio was 22.6× on Nov 11, 2026, against 20.0× a year earlier.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 22.6× | −15.6 |
| 2025 | Dec 31, 2025 | 38.2× | – |
See a number that looks wrong?